Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Mar 23, 2022 2:33pm
137 Views
Post# 34538622

RE:RE:RE:It's over

RE:RE:RE:It's over

Cannot disagree, hk! With recent posts my only assertion is that conspiracy theories and speculation serve no useful purpose except to vent ....and that's not always a bad thing. 

Over the last few months most of the FDA EUAs have been additions to tests that have already been approved. It's difficult to know how many applications are on the assembly line but based on the relatively few that have been approved since the first one, I suspect not many. Also, there have been several tests and iterations of others that have been recently removed by the FDA.

As with covid there are a lot of uncertainties around the future of rapid testing and thus the future of AcuVid. The bad news is we haven't heard anything and the good news is we haven't heard anything. As for no updates I believe investor views on this are (again with good reason) influenced by these very uncertainties and no strong indication as to how long one should have expected the application and review to take. There is certainly a sense or feeling that time is running out which is understandable if not full of assumptions.

I still believe an NR is necessary this week ....but that's only true if I'd provides a much clearer picture.

GLTY!!!

hk1966 wrote: Smokey the ongoing silence post PP raise is deafening and that speaks volumes. Wonder if Fia has been as forthcoming to the private investors as he has been with us over the last 1.5 months? 

 

<< Previous
Bullboard Posts
Next >>